GGrantIndex
← Leaderboards

Ghassan S Kassab

3dt Holdings, Llc

$29,569,425
Attributed
$55,208,150
Total exposure
43
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $7.8M · FY200525
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$55,208,150 · 43

By mechanism

R01$25,839,550 · 12
R44$11,526,171 · 6
U01$7,239,505 · 2
R43$6,644,967 · 21
OT2$3,633,137 · 1
R29$324,820 · 1

Top collaborators

Most similar at 3dt Holdings, Llc

Same institution · by research overlap

Others in their field

Top investigators on “Pressure

Research focus

PressureFamily SuidaeAffectAnimalsMechanicsBaseBlood VesselsPropertyMeasurementChronicPhysiologicalDevicesCoronaryIn VivoTissuesCardiacHeartAreaAnimal ModelDiagnosisResponseCostInnovationHealth Care Costs

Grant awards (99)

Software-guided Operative Planning of MitraClip Placement$1,065,759
R44 · FY2025 · HL
Mathematical Model-Based Optimization of CRT Response in Ischemia$771,198
R01 · FY2025 · HL · contact PI
Mechanisms of coronary flow heterogeneity: Implications for coronary sinus occlusion therapy$681,054
R01 · FY2025 · HL · contact PI
Fecobionics monitoring and prediction of biofeedback therapy outcome in patients with obstructed defecation.$370,000
R01 · FY2025 · DK
Mathematical Model-Based Optimization of CRT Response in Ischemia$765,101
R01 · FY2024 · HL · contact PI
Mechanisms of coronary flow heterogeneity: Implications for coronary sinus occlusion therapy$667,433
R01 · FY2024 · HL · contact PI
Pathophysiology, diagnosis and biofeedback therapy in fecal incontinence using fecobionics$652,851
R01 · FY2024 · DK
Defecation mechanisms and subtyping of constipation patients with Fecobionics$647,580
R01 · FY2024 · DK
Low Profile Transcatheter Aortic Valve Implant$497,401
R43 · FY2024 · HL
Software-guided Operative Planning of MitraClip Placement$480,989
R44 · FY2024 · HL
Novel Stabilization Catheter for His Pacing Lead Implant$437,461
R43 · FY2024 · HL
Novel Tracheostoma Device$400,000
R43 · FY2024 · CA
Fecobionics monitoring and prediction of biofeedback therapy outcome in patients with obstructed defecation.$355,200
R01 · FY2024 · DK
Software Tool for Optimization of CRT$293,653
R43 · FY2024 · HL
Biomechatronics Device for Diagnosis/Therapy of Anorectal Disorders$854,130
R44 · FY2023 · DK
Mathematical Model-Based Optimization of CRT Response in Ischemia$811,994
R01 · FY2023 · HL · contact PI
Pathophysiology, diagnosis and biofeedback therapy in fecal incontinence using fecobionics$717,356
R01 · FY2023 · DK
Mechanisms of coronary flow heterogeneity: Implications for coronary sinus occlusion therapy$681,054
R01 · FY2023 · HL · contact PI
Defecation mechanisms and subtyping of constipation patients with Fecobionics$559,894
R01 · FY2023 · DK
Fecobionics monitoring and prediction of biofeedback therapy outcome in patients with obstructed defecation.$370,000
R01 · FY2023 · DK
Biomechatronics Device for Diagnosis/Therapy of Anorectal Disorders$1,070,822
R44 · FY2022 · DK
Pathophysiology, diagnosis and biofeedback therapy in fecal incontinence using fecobionics$762,766
R01 · FY2022 · DK
Mechanisms of coronary flow heterogeneity: Implications for coronary sinus occlusion therapy$700,554
R01 · FY2022 · HL · contact PI
Defecation mechanisms and subtyping of constipation patients with Fecobionics$645,543
R01 · FY2022 · DK
Defecation mechanisms and subtyping of constipation patients with Fecobionics$645,591
R01 · FY2021 · DK
Biomechatronics Device for Diagnosis/Therapy of Anorectal Disorders$185,966
R44 · FY2021 · DK
VIRAL DELIVERED CARDIAC REGENERATION$52,000
R43 · FY2021 · HL
Roles of Ischemia and mechanical dyssynchrony in optimizing CRT responses$565,018
R01 · FY2020 · HL
Vasodilation Needle for Trans-Radial Access$376,567
R43 · FY2020 · HL
Left Atrial Appendage Inversion to Prevent Stroke$365,660
R43 · FY2020 · HL
New Access Kit for Lymphatic Interventions$339,866
R43 · FY2020 · GM
Fecobionics device for mapping colonic and anorectal neuromuscular function$152,464
OT2 · FY2020 · OD
Fecobionics device for mapping colonic and anorectal neuromuscular function$1,556,194
OT2 · FY2019 · OD
Device for Treatment of Cardiac No-Option Patients$991,925
R44 · FY2019 · HL
Roles of Ischemia and mechanical dyssynchrony in optimizing CRT responses$564,847
R01 · FY2019 · HL
Novel Leaflet Biomaterial for Pulmonary Artery Valve$447,184
R43 · FY2019 · HL
HLS-Diagnostic Balloon in Novel Venous Disease Model$364,201
R43 · FY2019 · HL
Small Peripheral Vessel Graft$325,534
R43 · FY2019 · HL
Real-Time Virtual Assessment of MitraClip Placement$289,679
R43 · FY2019 · HL
Fecobionics device for mapping colonic and anorectal neuromuscular function$1,675,013
OT2 · FY2018 · OD
Device for Treatment of Cardiac No-Option Patients$1,432,551
R44 · FY2018 · HL
Suction Device for Control and Accuracy of Transseptal Access$1,156,449
R44 · FY2018 · HL
Mild Hypothermia Catheter for Reperfusion Injury$1,140,998
R44 · FY2018 · HL
Multi-Scale Laws of Myocardial Growth and Remodeling$745,554
U01 · FY2018 · HL
Coronary Blood Flow: Integrated Theory and Experiments$650,460
U01 · FY2018 · HL
Roles of Ischemia and mechanical dyssynchrony in optimizing CRT responses$564,680
R01 · FY2018 · HL
Novel Biological Tissue for Vascular Patch$419,085
R43 · FY2018 · HL
Mild Hypothermia Catheter for Reperfusion Injury$855,323
R44 · FY2017 · HL
Suction Device for Control and Accuracy of Transseptal Access$808,638
R44 · FY2017 · HL
Multi-Scale Laws of Myocardial Growth and Remodeling$753,322
U01 · FY2017 · HL
Coronary Blood Flow: Integrated Theory and Experiments$657,332
U01 · FY2017 · HL
Roles of Ischemia and mechanical dyssynchrony in optimizing CRT responses$604,282
R01 · FY2017 · HL
HLS-Animal Model and Treatment of Chronic Venous Insufficiency$359,137
R43 · FY2017 · HL
Novel Fecobionics Device for Diagnosis of Anorectal Disorders$258,968
R43 · FY2017 · DK
Fecobionics device for mapping colonic and anorectal neuromuscular function$249,466
OT2 · FY2017 · OD
Coronary Post-Dilatation Catheter$781,382
R44 · FY2016 · HL
Multi-Scale Laws of Myocardial Growth and Remodeling$760,865
U01 · FY2016 · HL
Minimally Invasive Ventricular Polymeric Injection for Treatment of Heart Failure$748,628
R01 · FY2016 · HL
Coronary Blood Flow: Integrated Theory and Experiments$675,800
U01 · FY2016 · HL
Micro-Mechanical Role of Hypertension in Intimal Hyperplasia$621,551
R01 · FY2016 · HL · contact PI
Device for Treatment of Cardiac No-Option Patients$285,407
R43 · FY2016 · HL
Multi-Scale Laws of Myocardial Growth and Remodeling$760,306
U01 · FY2015 · HL
Minimally Invasive Ventricular Polymeric Injection for Treatment of Heart Failure$751,205
R01 · FY2015 · HL
Coronary Post-Dilatation Catheter$701,239
R44 · FY2015 · HL
Coronary Blood Flow: Integrated Theory and Experiments$664,218
U01 · FY2015 · HL
Micro-Mechanical Role of Hypertension in Intimal Hyperplasia$612,226
R01 · FY2015 · HL · contact PI
Valvuloplasty Sizing Balloon Catheter$237,021
R43 · FY2015 · HL
Multi-Scale Laws of Myocardial Growth and Remodeling$811,109
U01 · FY2014 · HL
Minimally Invasive Ventricular Polymeric Injection for Treatment of Heart Failure$749,658
R01 · FY2014 · HL
Micro-Mechanical Role of Hypertension in Intimal Hyperplasia$628,720
R01 · FY2014 · HL · contact PI
Mild Hypothermia Catheter for Reperfusion Injury$230,895
R43 · FY2014 · HL
Minimally Invasive Ventricular Polymeric Injection for Treatment of Heart Failure$779,694
R01 · FY2013 · HL
Coronary Blood Flow: Integrated Theory and Experiments$760,539
U01 · FY2013 · HL
Micro-Mechanical Role of Hypertension in Intimal Hyperplasia$537,566
R01 · FY2013 · HL · contact PI
Stabilization Device for Transseptal Access$269,255
R43 · FY2013 · HL
Multi-Functional Guidewire for Peripheral Vasculature$199,756
R43 · FY2013 · HL
Coronary Post-Dilatation Catheter$196,237
R43 · FY2013 · HL
CT-Based Diagnosis of Diffuse Coronary Artery Disease$409,086
R01 · FY2012 · HL · contact PI
The Role of Shear Stress in Heart Failure$370,173
R01 · FY2012 · HL · contact PI
CT-Based Diagnosis of Diffuse Coronary Artery Disease$405,120
R01 · FY2011 · HL · contact PI
The Role of Shear Stress in Heart Failure$373,983
R01 · FY2011 · HL · contact PI
Pressure and Flow-Induced Remodeling of Coronary Arteries$543,193
R01 · FY2010 · HL · contact PI
A Validated Micro-Structural Mechanical Model of Coronary Arteries$423,822
R01 · FY2010 · HL · contact PI
CT-Based Diagnosis of Diffuse Coronary Artery Disease$409,672
R01 · FY2010 · HL · contact PI
The Role of Shear Stress in Heart Failure$374,051
R01 · FY2010 · HL · contact PI
Pressure and Flow-Induced Remodeling of Coronary Arteries$645,712
R01 · FY2009 · HL · contact PI
CT-Based Diagnosis of Diffuse Coronary Artery Disease$488,644
R01 · FY2009 · HL · contact PI
A Validated Micro-Structural Mechanical Model of Coronary Arteries$422,395
R01 · FY2009 · HL · contact PI
The Role of Shear Stress in Heart Failure$369,019
R01 · FY2009 · HL · contact PI
A Validated Micro-Structural Mechanical Model of Coronary Arteries$412,617
R01 · FY2008 · HL · contact PI
The Role of Shear Stress in Heart Failure$359,953
R01 · FY2008 · HL · contact PI
Pressure and Flow Induced Remodeling of Coronary Artery$332,051
R01 · FY2006 · HL · contact PI
Pressure and Flow Induced Remodeling of Coronary Artery$301,693
R01 · FY2005 · HL
Pressure and Flow Induced Remodeling of Coronary Artery$40,071
R01 · FY2005 · HL
Pressure and Flow Induced Remodeling of Coronary Artery$299,939
R01 · FY2004 · HL
Pressure and Flow Induced Remodeling of Coronary Artery$325,112
R01 · FY2003 · HL
PRESSURE AND FLOW INDUCED REMODELING OF CORONARY VESSELS$110,956
R29 · FY2002 · HL
PRESSURE AND FLOW INDUCED REMODELING OF CORONARY VESSELS$108,512
R29 · FY2001 · HL
PRESSURE AND FLOW INDUCED REMODELING OF CORONARY VESSELS$105,352
R29 · FY2000 · HL